Literature DB >> 21270105

In vivo magnetic resonance imaging to detect biliary excretion of 19F-labeled drug in mice.

Jean-Pierre Raufman1, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A Kane, Da Shi, Rao Gullapalli, James Polli.   

Abstract

Isoflurane is an inhaled halogenated hydrocarbon anesthetic commonly used for animal research. In our quest to develop a method for measuring bile acid transport in live animals using (19)F magnetic resonance (MR) imaging, it occurred to us that isoflurane, which contains five fluorines per molecule and is probably widely distributed, would provide an excellent test drug to evaluate the merits of this approach. Experiments in 20- to 28-g male C57BL/6 mice were performed using a horizontal bore scanner with a 30-mm (19)F/(1)H dual-tuned surface coil used to transmit and receive radiofrequency signals at 300.28 MHz for (1)H and 282.55 MHz for (19)F nuclei. Proton MR imaging was used to identify the mouse gallbladder in vivo, which was verified by anatomical dissection. Subsequent experiments in mice inhaling 1.5% isoflurane for 1 to 2 h revealed robust (19)F signals from the gallbladder, verified by overlying (1)H and (19)F signals. No (19)F signal was detected in mice anesthetized with nonhalogenated anesthetics. The presence of isoflurane in gallbladder bile of isoflurane-treated mice was verified using liquid chromatography-mass spectrometry. Gallbladder bile isoflurane content ranged from 3.2 to 4.7 μg. The data presented here provide proof of concept that this novel approach can be used for in vivo measurement of biliary excretion of both existing and novel (19)F-labeled drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270105      PMCID: PMC3082377          DOI: 10.1124/dmd.110.037358

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  16 in total

1.  Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane.

Authors:  H Wissing; I Kuhn; S Rietbrock; U Fuhr
Journal:  Br J Anaesth       Date:  2000-04       Impact factor: 9.166

Review 2.  Adverse drug reactions with halogenated anesthetics.

Authors:  E D Kharasch
Journal:  Clin Pharmacol Ther       Date:  2008-05-28       Impact factor: 6.875

3.  Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury.

Authors:  D Njoku; M J Laster; D H Gong; E I Eger; G F Reed; J L Martin
Journal:  Anesth Analg       Date:  1997-01       Impact factor: 5.108

4.  Biliary lipid composition in idiopathic bile acid malabsorption.

Authors:  M Fracchia; S Pellegrino; P Secreto; A Pera; G Galatola
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

5.  Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.

Authors:  E D Kharasch; K E Thummel
Journal:  Anesthesiology       Date:  1993-10       Impact factor: 7.892

6.  Bile acid pool size and gallbladder storage capacity in gallstone disease.

Authors:  K Nilsell
Journal:  Scand J Gastroenterol       Date:  1990-04       Impact factor: 2.423

7.  Noninvasive observations of fluorinated anesthetics in rabbit brain by fluorine-19 nuclear magnetic resonance.

Authors:  A M Wyrwicz; M H Pszenny; J C Schofield; P C Tillman; R E Gordon; P A Martin
Journal:  Science       Date:  1983-10-28       Impact factor: 47.728

8.  Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for (19)F MRI.

Authors:  Zhong-Xing Jiang; Xin Liu; Eun-Kee Jeong; Yihua Bruce Yu
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane.

Authors:  D D Christ; H Satoh; J G Kenna; L R Pohl
Journal:  Drug Metab Dispos       Date:  1988 Jan-Feb       Impact factor: 3.922

10.  In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue.

Authors:  Sander M Houten; David H Volle; Carolyn L Cummins; David J Mangelsdorf; Johan Auwerx
Journal:  Mol Endocrinol       Date:  2007-04-10
View more
  3 in total

1.  Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport.

Authors:  Jessica Felton; Kunrong Cheng; Anan Said; Aaron C Shang; Su Xu; Diana Vivian; Melissa Metry; James E Polli; Jean-Pierre Raufman
Journal:  J Vis Exp       Date:  2016-11-27       Impact factor: 1.355

2.  Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Valerie Whiterock; Drew Witter; Kimberley A Lentz; Kenneth S Santone; Jean-Pierre Raufman; James E Polli
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

3.  In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Edwin H Kriel; Paul A Dawson; Jean-Pierre Raufman; James E Polli
Journal:  Mol Pharm       Date:  2014-04-18       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.